Welcome to the Washington University ACTU Community Advisory Board WEB Page

We need your input!  Anyone is welcome to attend meetings and become a member of the CAB.  Meet with the ACTU investigators and staff.


Jay, a Community Advisory Board Member of the ACTU, and Dr. Erin Quirk meet following a "protocols review meeting".

CAB Mission Statement

The mission of the Community Advisory Boards (CABs) of the AIDS Clinical Trials Group (ACTG) is to integrate community involvement in the AIDS Clinical Trials Units (ACTU's) in order to advance HIV/AIDS research.

Purpose of the Community Advisory Boards
CAB's provide an opportunity for affected communities, especially clinical trials participants to:

  • understand the clinical research process

  • voice concerns regarding specific clinical studies, their development, implementation and outcomes
  • give assistance concerning issues related to the accrual and retention of trial participants
  • give clinical trial participants necessary advocacy
  • forge a viable partnership that will lead to improved knowledge of HIV/AIDS disease
  • give a means to address grievance issue, and
  • promote ethical research purposes and practices.

Upcoming Meeting Dates

The CAB meetings are held on Wednesdays once monthly with a recess during the summer. Meetings are at 6:00 pm in the Conference Room at 4570 Children's Place., St. Louis, MO. When available, the updated meeting agenda will be posted so that you can  review the meeting details!

Next meeting date:
September 3, 2008
 

The date of the next protocol review meeting is not yet scheduled.  All meetings are at noon. These meetings offer the opportunity to discuss the protocols that may be conducted at our site and to seek community input. If you are interested in attending a meeting, please call 314-454-8275, to be sure it is not cancelled.

Why do we do the protocol review meetings?

  • To bring the ACTU staff and members of the community together to discuss studies relevant to the St. Louis area community

  • To be sure we provide studies that are of interest to potential participants

  • To be sure we have broad availability of studies

  • To identify troublesome studies before we sign up for them

  • To educate all involved
     

wpeC.jpg (6418 bytes)Do you want to have input and learn more about the development of HIV/AIDS treatment trials in St. Louis?

Then join us at our next meeting to find out how you can make a difference.

 

What is the CAB?

What We Do

Who Can Join?

Local Community Advisory Boards (or CAB's) were mandated in 1991 by the national AIDS Clinical Trials Group to be formed throughout the country. The Washington University AIDS Clinical Trial Unit’s CAB was formed in 1988. The role of the CAB is to assist the local ACTU site in the selection and implementation of trials at that site. Also, the CAB acts as a liaison to the community, educating people about participation in clinical trials.

  • Help represent the interests of our communities

  • Determine allocation of limited spaces for popular trials.

  • Access up-to-date information and education from ACTU staff regarding trials, study medications, etc.

  • Get your questions about trials answered.

All persons from diverse communities are welcome regardless of medical background, health, or HIV status.

We especially encourage those who have taken part in a clinical trial or are currently enrolled in one to participate in the CAB

Everyone is welcome!

Washington University CAB

 
 
Meetings are held at:
Washington University School of Medicine
4570 Children's Place
Suite 1200
St. Louis, Missouri
    Grievance or just have questions about clinical trials?

Members of our CAB are also clinical trial participants and are available to speak with you. Leave a voice message at (314) 454-8275 and a CAB member will get back to you.

For more information please call:

Susan Wightman, RN, BSN, ACRN
Box 8051
660 S. Euclid Ave.
St. Louis, MO 63110
314-454-8275
email: swightma@im.wustl.edu

This page was last updated 07/18/08

quotecarinsurance.com
 

Division of Infectious Diseases
Department of Medicine
Washington University School of Medicine